Literature DB >> 22018622

GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.

Ana Bobinac1, N Job A van Exel, Frans F H Rutten, Werner B F Brouwer.   

Abstract

Estimates of WTP per QALY can be taken as an indication of the monetary value of health gains, which may carry information regarding the appropriate height of the cost-effectiveness threshold. Given the far-reaching consequences choosing a particular threshold, and thus the potential relevance of WTP per QALY estimates, it is important to address the validity of these estimates. This study addresses this issue. Our findings offer little support to the validity of WTP per QALY estimates obtained in this study. Implications for general WTP per QALY estimates and further research are discussed.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Year:  2011        PMID: 22018622     DOI: 10.1016/j.jhealeco.2011.09.004

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  17 in total

1.  Exploring a new method for deriving the monetary value of a QALY.

Authors:  Carl Tilling; Marieke Krol; Arthur E Attema; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2015-08-20

2.  The value of a QALY: individual willingness to pay for health gains under risk.

Authors:  Ana Bobinac; Job van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

3.  Value of a QALY and VSI estimated with the chained approach.

Authors:  S Olofsson; U-G Gerdtham; L Hultkrantz; U Persson
Journal:  Eur J Health Econ       Date:  2019-06-06

4.  When is it too expensive? Cost-effectiveness thresholds and health care decision-making.

Authors:  Werner Brouwer; Pieter van Baal; Job van Exel; Matthijs Versteegh
Journal:  Eur J Health Econ       Date:  2019-03

Review 5.  Productivity costs in economic evaluations: past, present, future.

Authors:  Marieke Krol; Werner Brouwer; Frans Rutten
Journal:  Pharmacoeconomics       Date:  2013-07       Impact factor: 4.981

6.  The societal monetary value of a QALY associated with EQ-5D-3L health gains.

Authors:  Laura Vallejo-Torres; Borja García-Lorenzo; Oliver Rivero-Arias; José Luis Pinto-Prades
Journal:  Eur J Health Econ       Date:  2019-11-28

7.  Consistent defined threshold and equity in health.

Authors:  Shekoufeh Nikfar; Zaheer-Ud-Din Babar; Rassoul Dinarvand; Abbas Kebriaeezadeh; Mohammad Abdollahi
Journal:  Daru       Date:  2015-02-10       Impact factor: 3.117

8.  Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.

Authors:  Jesus Martín-Fernández; Elena Polentinos-Castro; Ma Isabel del Cura-González; Gloria Ariza-Cardiel; Victor Abraira; Ana Isabel Gil-LaCruz; Sonia García-Pérez
Journal:  BMC Health Serv Res       Date:  2014-07-03       Impact factor: 2.655

9.  Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity.

Authors:  A Mavrodi; V Aletras; A Spanou; D Niakas
Journal:  Pharmacoecon Open       Date:  2017-12

10.  The impact of the design of payment scales on the willingness to pay for health gains.

Authors:  Lotte Soeteman; Job van Exel; Ana Bobinac
Journal:  Eur J Health Econ       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.